Allan Albig

Dr. Allan Albig

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Developmental Biology
Verified
Journal Article
Closed access
BLBryce LaFoya
Bryce LaFoya
JMJordan A. Munroe
Jordan A. Munroe
MMMasum M. Mia
Masum M. Mia
MDMichael A. Detweiler
Michael A. Detweiler
JCJacob J. Crow
Jacob J. Crow
AAAllan Albig
Allan Albig

Verified
Journal Article
Open access
PDF file
BLBryce LaFoya
Bryce LaFoya
JMJordan A. Munroe
Jordan A. Munroe
AMAlison Miyamoto
Alison Miyamoto
MDMichael A. Detweiler
Michael A. Detweiler
JCJacob Crow
Jacob Crow
AAAllan Albig
Allan Albig
The traditional view of integrins portrays these highly conserved cell surface receptors as mediators of cellular attachment to the extracellular matrix (ECM), and to a lesser degree, as coordinators of leukocyte adhesion to the endothelium. These canonical activities are indispensable; however, there is also a wide variety of integrin functions mediated by non-ECM ligands that transcend the traditional roles of integrins. Some of these unorthodox roles involve cell-cell interactions and are engaged to support immune functions such as leukocyte transmigration, recognition of opsonization factors, and stimulation of neutrophil extracellular traps. Other cell-cell interactions mediated by integrins include hematopoietic stem cell and tumor cell homing to target tissues. Integrins also serve as cell-surface receptors for various growth factors, hormones, and small molecules. Interestingly, integrins have also been exploited by a wide variety of organisms including viruses and bacteria to support infectious activities such as cellular adhesion and/or cellular internalization. Additionally, the disruption of integrin function through the use of soluble integrin ligands is a common strategy adopted by several parasites in order to inhibit blood clotting during hematophagy, or by venomous snakes to kill prey. In this review, we strive to go beyond the matrix and summarize non-ECM ligands that interact with integrins in order to highlight these non-traditional functions of integrins.

1 February 2016 in Experimental Cell Research
Verified
Journal Article
Open access
PDPeter Deford
Peter Deford
KBKasey Brown
Kasey Brown
RRRae Lee Richards
Rae Lee Richards
AKAric King
Aric King
KNKristin Newburn
Kristin Newburn
AAAllan Albig
Allan Albig
Canonical Notch signaling involves Notch receptor activation via interaction with cell surface bound Notch ligand. Recent findings also indicate that Notch signaling may be modulated by cross-talk with other signaling mechanisms. The ECM protein MAGP2 was previously shown to regulate Notch in a cell type dependent manner, although the molecular details of this interaction have not been dissected. Here, we report that MAGP2 cell type specific control of Notch is independent of individual Notch receptor-ligand combinations but dependent on interaction with RGD binding integrins. Overexpressed MAGP2 was found to suppress transcriptional activity from the Notch responsive Hes1 promoter activity in endothelial cells, while overexpression of a RGD→RGE MAGP2 mutant increased Notch signaling in the same cell type. This effect was not unique to MAGP2 since the RGD domain of the ECM protein EGFL7 was also found to be an important modulator of Hes1 promoter activity. Independently of MAGP2 or EGFL7, inhibition of RGD-binding integrins with soluble RGD peptides also increased accumulation of active N1ICD fragments and Notch responsive promoter activity independently of changes in Notch1, Jag1, or Dll4 expression. Finally, β1 or β3 integrin blocking antibodies also enhanced Notch signaling. Collectively, these results answer the question of how MAGP2 controls cell type dependent Notch signaling, but more importantly uncover a new mechanism to understand how extracellular matrices and cellular environments impact Notch signaling.

1 January 2013 in Microvascular Research
Verified
Journal Article
Closed access
BSBikram Sharma
Bikram Sharma
AAAllan Albig
Allan Albig

17 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BLBryce LaFoya
Bryce LaFoya
JMJordan A Munroe
Jordan A Munroe
AAAllan Albig
Allan Albig
Resveratrol is a polyphenolic compound produced by plants which makes its way into the human diet through plant-based foods. It has been shown to provide many health benefits, helping to ward of age-related diseases and promoting cardiovascular health. Additionally, resveratrol is a potent activator of the Notch signaling pathway. While resveratrol receives the most attention as a polyphenolic nutraceutical, other compounds with similar structures may be more potent regulators of specific cellular processes. Here, we compare resveratrol, apigenin, chrysin, genistein, luteolin, myricetin, piceatannol, pterostilbene, and quercetin for their ability to regulate Notch signaling. In addition, we compare the ability of these polyphenolic compounds to regulate endothelial cell viability, proliferation, and migration. Out of these compounds we found that resveratrol is the best activator of Notch signaling, however, other similar compounds are also capable of stimulating Notch. We also discovered that several of these polyphenols were able to inhibit endothelial cell proliferation. Finally, we found that many of these polyphenols are potent inhibitors of endothelial migration during wound healing assays. These findings provide the first side-by-side comparison of the regulation of Notch signaling, and endothelial cell proliferation and migration, by nine polyphenolic compounds.

18 June 2013 in Cancer Microenvironment
Verified
Journal Article
Closed access
PDF file
BSBikram Sharma
Bikram Sharma
MRMegan D. Ramus
Megan D. Ramus
CKChristopher T. Kirkwood
Christopher T. Kirkwood
ESEmma E. Sperry
Emma E. Sperry
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
AAAllan Albig
Allan Albig